Acute Myeloid Leukemia PDX Models

Most commercially available blood cancer Patient Derived Xenograft (PDX) models are transient in nature, and non-transferable through passages (not renewable), without disease symptoms or mortality. However, CrownBio’s PDX models for blood cancer are permanent, and allow the study of disease recurrence after initial treatment challenge and the efficacy testing of novel agents against drug resistance. The CrownBio AML PDX collection consists several models, including models with patient-relevant mutations e.g. BCR/ABL(+). More

MODEL ID CANCER TYPE SUBTYPE models per page
AM5512 Acute Myeloid Leukemia M7? VIEW MODEL Details
AM7577 Acute Myeloid Leukemia M5 VIEW MODEL Details